Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.

Featured

Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Featured

Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Featured

Cell and Gene Therapy

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

Featured

Computational Life Sciences

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Featured

Cell and Gene Therapy

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Claire Aldridge, PhD

May 15, 2023

Leveraging AI Models To Improve Safety of Gene Therapy

Featured

Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Nick Ketz, PhD

May 3, 2023

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Featured

Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Andrew Busey & Kent Wakeford

March 27, 2023

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Featured

Cell and Gene Therapy

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Austin Day, PhD

March 2, 2023

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Featured

Computational Life Sciences

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Austin Day, PhD

February 10, 2023

Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Featured

Computational Life Sciences

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

April 18, 2023

Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.

Featured

Cell and Gene Therapy

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Jill Roughan, PhD

April 4, 2023

Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Featured

Cell and Gene Therapy

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

March 22, 2023

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Featured

Cell and Gene Therapy

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Nick Ketz, PhD

March 8, 2023

Transformer based architectures are uniquely efficient and powerful when used to process structured data. Read this blog to learn how they can be customized, adapted and applied to AAV construct optimization.

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Featured

Cell and Gene Therapy

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Jill Roughan, PhD

February 23, 2023

In this article, we take a look at the role of viral vectors in gene therapy clinical trials, including current challenges and leveraging artificial intelligence to advance the field.

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Featured

Computational Life Sciences

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Jill Roughan, PhD

February 14, 2023

Want to know more about the foundational types and common tools to use for RNA-Seq data visualization in gene therapy development? Read this blog to find out.

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Featured

Computational Life Sciences

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Jill Roughan, PhD

February 7, 2023

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

Form Bio Resources

Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Nick Ketz, PhD

May 3, 2023

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Computational Life Sciences

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

April 18, 2023

Cell and Gene Therapy

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

March 22, 2023

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Board of Directors

Johnnn

Doe

,

Ph.D.

CEO

Johnn

Doe

,

Ph.D.

CEO

John

Doe

,

Ph.D.

CEO

Johnnn

Doe

,

Ph.D.

CEO

Form Bio Resources

Cell and Gene Therapy

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Cell and Gene Therapy

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Form Bio Blog

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Leveraging AI Models To Improve Safety of Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Leveraging AI Models To Improve Safety of Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Maximizing Therapeutic Efficacy Through Codon Substitution Design

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Form Bio Resources

Leveraging AI Models To Improve Safety of Gene Therapy

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Board of Directors

Johnnn

Doe

,

Ph.D.

Johnn

Doe

,

Ph.D.

John

Doe

,

Ph.D.

Johnnn

Doe

,

Ph.D.

Form your future breakthroughs

See how Form can empower you

Get informed

Form Bio Resources

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing